Published in Ann N Y Acad Sci on February 01, 2009
Reactive oxygen species in cancer. Free Radic Res (2010) 3.20
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06
Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell (2010) 2.43
Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med (2010) 1.84
Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology (2010) 1.82
Is HCMV a tumor promoter? Virus Res (2010) 1.81
A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol (2009) 1.70
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer (2012) 1.59
Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol (2012) 1.56
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget (2012) 1.55
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int (2012) 1.53
JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res (2012) 1.52
Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis. PLoS One (2014) 1.51
Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS One (2016) 1.48
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43
Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae (2010) 1.40
Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc Natl Acad Sci U S A (2010) 1.26
Leveraging the biology of adversity to address the roots of disparities in health and development. Proc Natl Acad Sci U S A (2012) 1.25
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett (2010) 1.22
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer (2011) 1.19
The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes. Exp Mol Pathol (2010) 1.18
Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med (2013) 1.17
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis (2009) 1.15
Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS One (2012) 1.08
Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. World J Surg (2015) 1.05
Inhibition of TNF-α-mediated NF-κB Transcriptional Activity in HepG2 Cells by Dammarane-type Saponins from Panax ginseng Leaves. J Ginseng Res (2012) 1.04
Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J Gastroenterol (2012) 1.04
MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model. Cancer Res (2011) 1.02
An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials. PLoS One (2014) 1.01
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol (2015) 0.97
γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent. Br J Pharmacol (2011) 0.97
Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation. Mol Cancer (2010) 0.96
Genetic deletion of AEG-1 prevents hepatocarcinogenesis. Cancer Res (2014) 0.96
P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells. J Biol Chem (2010) 0.95
KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study. PLoS One (2011) 0.95
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol (2014) 0.94
Modulation of apoptotic signaling by the hepatitis B virus X protein. Viruses (2012) 0.93
From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med (2012) 0.93
Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol (2011) 0.92
Alcoholic liver disease - Hepatocellular carcinoma transformation. J Gastrointest Oncol (2012) 0.92
Cytochrome P450 2E1 inhibition prevents hepatic carcinogenesis induced by diethylnitrosamine in alcohol-fed rats. Hepatobiliary Surg Nutr (2012) 0.91
Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells. Evid Based Complement Alternat Med (2013) 0.90
Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma. Life Sci (2012) 0.89
The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. J Virol (2014) 0.88
Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma. Mol Cancer (2015) 0.88
A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol (2015) 0.87
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. J Hepatol (2015) 0.87
Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences. World J Gastroenterol (2010) 0.86
Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses (2013) 0.85
Involvement of DNA damage response pathways in hepatocellular carcinoma. Biomed Res Int (2014) 0.84
High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity. Cancer Res (2015) 0.84
Epidermal growth factor protects the apical junctional complexes from hydrogen peroxide in bile duct epithelium. Lab Invest (2011) 0.84
Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice. PLoS One (2010) 0.84
The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection--a retrospective study. PLoS One (2015) 0.83
Immunology of hepatocellular carcinoma. World J Hepatol (2015) 0.83
Roles of CXCL5 on migration and invasion of liver cancer cells. J Transl Med (2014) 0.83
Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study. PLoS One (2014) 0.82
Role of Antioxidants and Natural Products in Inflammation. Oxid Med Cell Longev (2016) 0.82
HCC development is associated to peripheral insulin resistance in a mouse model of NASH. PLoS One (2014) 0.81
Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer. Cytokine (2010) 0.81
Rather than Rs1800796 polymorphism, expression of interleukin-6 is associated with disease progression of chronic HBV infection in a Chinese Han population. Dis Markers (2013) 0.81
Fish consumption and risk of gastrointestinal cancers: a meta-analysis of cohort studies. World J Gastroenterol (2014) 0.80
Gastric cancer is associated with NOS2 -954G/C polymorphism and environmental factors in a Brazilian population. BMC Gastroenterol (2010) 0.80
Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB Activity. J Clin Cell Immunol (2015) 0.80
Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model. Oncotarget (2016) 0.80
Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China. BMJ Open (2014) 0.80
Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal(-/-) Mice. Am J Pathol (2015) 0.80
MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation. World J Gastroenterol (2013) 0.80
Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma. Front Oncol (2014) 0.80
Tumor necrosis factor-α-induced a disintegrin and metalloprotease 10 increases apoptosis resistance in prostate cancer cells. Oncol Lett (2014) 0.79
New Insights into Orphan Nuclear Receptor SHP in Liver Cancer. Nucl Receptor Res (2015) 0.79
Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection. Clin Dev Immunol (2013) 0.79
A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma. Funct Integr Genomics (2011) 0.78
Myenteric denervation in gastric carcinogenesis: differential modulation of nitric oxide and annexin-A1. Int J Clin Exp Pathol (2012) 0.78
Molecular characterization of hepatocarcinogenesis using mouse models. Dis Model Mech (2015) 0.78
A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines. Cancer Lett (2015) 0.78
Host Responses and Regulation by NFκB Signaling in the Liver and Liver Epithelial Cells Infected with A Novel Tick-borne Bunyavirus. Sci Rep (2015) 0.78
Toxic stress, inflammation and symptomatology of chronic complications in diabetes. World J Diabetes (2015) 0.77
Virtual Screening for Finding Novel COX-2 Inhibitors as Antitumor Agents. Open Med Chem J (2012) 0.77
Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection. Clin Cancer Res (2015) 0.77
Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. World J Gastroenterol (2016) 0.76
Perihepatic lymph node enlargement is a negative predictor of liver cancer development in chronic hepatitis C patients. J Gastroenterol (2012) 0.76
The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis. PLoS One (2016) 0.76
Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma. PLoS One (2015) 0.76
Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assay. Sci Rep (2016) 0.75
Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth period. Cell Cycle (2016) 0.75
Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma. Oncotarget (2016) 0.75
Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World J Gastroenterol (2016) 0.75
Interleukin-6 (IL-6) serum concentrations in dogs with hepatitis and hepatic tumours compared with those with extra-hepatic inflammation and tumours. Comp Clin Path (2010) 0.75
Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action. CPT Pharmacometrics Syst Pharmacol (2015) 0.75
Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink. Cancer Epidemiol (2016) 0.75
Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation. Oncotarget (2016) 0.75
STAT3 activation in infection and infection-associated cancer. Mol Cell Endocrinol (2017) 0.75
Accelerated carcinogenesis following liver resection in chronically inflamed livers: A window of opportunity for treatment. Biomed Rep (2017) 0.75
Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1. Cancer Lett (2015) 0.75
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma. World J Gastroenterol (2017) 0.75
Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma. J Hepatocell Carcinoma (2014) 0.75
Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncol Lett (2017) 0.75
The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study. J Epidemiol (2017) 0.75
Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke (2000) 3.74
Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology (2004) 3.21
Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med (1991) 3.14
Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A (2001) 2.93
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2010) 2.39
Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem (2008) 2.24
Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology (2000) 2.24
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol (2000) 2.22
Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology (2007) 2.17
New therapies for hepatocellular carcinoma. Oncogene (2006) 2.05
Guidelines for the treatment of acute ischaemic stroke. Neurologia (2011) 2.05
Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology (1993) 1.95
[Efficacy of ondansetron in the prevention of nausea and vomiting after laparoscopic cholecystectomy]. Rev Esp Anestesiol Reanim (1997) 1.92
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut (2000) 1.82
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest (1992) 1.82
Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke (1999) 1.80
Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol (2000) 1.73
Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology (1998) 1.67
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
The problem of aging human remains and living individuals: a review. Forensic Sci Int (2009) 1.59
Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma. Hepatology (2001) 1.56
Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology (1996) 1.56
[Spanish doctoral dissertations on anesthesiology and the scientific publications of their authors]. Rev Esp Anestesiol Reanim (2002) 1.51
Genetic markers: association study in migraine. Cephalalgia (1995) 1.48
Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.48
Prevention of post dural puncture headache with epidural-administered dextran 40. Reg Anesth (1993) 1.48
[Problem/case-based learning compared to lectures for acquiring knowledge of air embolism in continuing medical education]. Rev Esp Anestesiol Reanim (2008) 1.47
Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl (2001) 1.44
Magnesium binding to the bacterial chemotaxis protein CheY results in large conformational changes involving its functional surface. J Mol Biol (1994) 1.44
A new method for kidney vascularization. Arch Surg (1968) 1.43
Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum (1994) 1.42
The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology (2004) 1.40
[Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery]. Rev Esp Anestesiol Reanim (2003) 1.40
Rituximab in CD20 positive multiple myeloma. Leukemia (2007) 1.40
[Delayed improvement of anemia treated with intravenous iron and epoetin alfa after hip replacement surgery]. Rev Esp Anestesiol Reanim (2005) 1.39
Thrombocytopenia associated with carbamazepine: a case series. J Clin Psychiatry (1991) 1.39
Liver transplantation in cirrhotic patients over 60 years of age. Rev Esp Enferm Dig (1998) 1.38
Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev (2003) 1.37
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model. Antimicrob Agents Chemother (2002) 1.32
Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology (1994) 1.32
Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology (1997) 1.25
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl (2001) 1.25
Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon. J Hepatol (1994) 1.25
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax (2003) 1.22
Accessory vascularization to the kidney. Rev Surg (1968) 1.21
Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry (2005) 1.21
Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology (1989) 1.20
Duration of glutamate release after acute ischemic stroke. Stroke (1997) 1.19
Epidemiology of chronic daily headache. Curr Pain Headache Rep (2001) 1.19
Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology. Immunol Rev (1990) 1.18
Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones. Antimicrob Agents Chemother (2001) 1.18
Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J Immunol (2000) 1.17
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol (2010) 1.15
Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. Oncogene (2008) 1.15
Transmission of hepatitis C virus infection to tree shrews. Virology (1998) 1.14
Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell Immunol (1992) 1.12
Central and peripheral corneal thickness in full-term newborns by ultrasonic pachymetry. Invest Ophthalmol Vis Sci (1992) 1.11
The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. J Infect Dis (2000) 1.11
Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology (1992) 1.10
Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis (2009) 1.10
Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months. Neurology (2009) 1.09
Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset. J Rheumatol (1989) 1.08
Amphiregulin: a new growth factor in hepatocarcinogenesis. Cancer Lett (2007) 1.08
Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol (1998) 1.07
[Cardiorespiratory arrest and afterwards what?]. Med Clin (Barc) (1999) 1.06
High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. Neurology (2008) 1.05
Identification of a novel adhesion molecule in human leukocytes by monoclonal antibody LB-2. FEBS Lett (1987) 1.05
Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology (1993) 1.05
Liver cytoprotection by prostaglandins. Pharmacol Ther (1993) 1.05
Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia (2006) 1.04
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology (2001) 1.04
Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth (2011) 1.04
Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology (1996) 1.03
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology (1995) 1.03
Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost (2005) 1.03
Thermodynamic analysis of the chemotactic protein from Escherichia coli, CheY. Biochemistry (1993) 1.02
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma. Cancer Gene Ther (2010) 1.02
The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol (1991) 1.02
Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. Gut (2006) 1.02
The response of the hepatocyte to ischemia. Liver Int (2007) 1.01
Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity. Eur J Immunol (2001) 1.01
S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol (2001) 1.01
Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes. J Antimicrob Chemother (1994) 1.01
Polarity of immunogens: implications for vaccine design. Eur J Immunol (1990) 1.00
Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice. Gut (2004) 1.00
Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology (1997) 1.00
In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. J Antimicrob Chemother (2007) 1.00
Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology (1997) 0.99
Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol (1997) 0.99
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers. Antimicrob Agents Chemother (1996) 0.99
N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. J Interferon Res (1993) 0.99